Maria Angelica Selim

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma”.

Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002203

N/A

1.8DataRank · unranked

80 citations

Smita K. Nair, Norma E. Farrow, Karenia Landa, Maria Angelica Selim, Carol Ann Wiggs +6 more

Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanoma

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005052

N/A

0.703DataRank · unranked

42 citations

Michael C. Brown, Norma E. Farrow, Karenia Landa, Rami N. Al‐Rohil, Maria Angelica Selim +10 more

Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma

Annals of Surgical Oncology(2020)10.1245/s10434-020-09277-w

N/A

0DataRank · unranked

19 citations

Eda K. Holl, Jeanne Jung, Junheng Gao, Sin‐Ho Jung, Rami N. Al‐Rohil +8 more

Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detection

Cancer Immunology Immunotherapy(2020)10.1007/s00262-020-02698-2

N/A

0DataRank · unranked

8 citations

Aaron D Therien, Eda K. Holl, Rami N. Al‐Rohil, Maria Angelica Selim, Nellie E. Farrow +7 more